ロード中...
A novel proteasome inhibitor NPI-0052 as an anticancer therapy
Proteasome inhibitor Bortezomib/Velcade has emerged as an effective anticancer therapy for the treatment of relapsed and/or refractory multiple myeloma (MM), but prolonged treatment can be associated with toxicity and development of drug resistance. In this review, we discuss the recent discovery of...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2360698/ https://ncbi.nlm.nih.gov/pubmed/17047643 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6603406 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|